PetVivo Holdings, Inc. (PETV)
USD 0.63
(0.0%)
USD 0.63
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 968.7 Thousand USD | 5.62% |
| 2023 | 917.16 Thousand USD | 693.49% |
| 2022 | 115.58 Thousand USD | 818.95% |
| 2021 | 12.57 Thousand USD | 250.56% |
| 2020 | 3588.00 USD | -95.4% |
| 2019 | 77.93 Thousand USD | 5061.32% |
| 2018 | 1510.00 USD | -78.8% |
| 2017 | 7124.00 USD | -90.5% |
| 2016 | 75 Thousand USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 968.7 Thousand USD | 5.62% |
| 2024 Q1 | 117.18 Thousand USD | -6.7% |
| 2024 Q2 | 207.36 Thousand USD | 76.96% |
| 2024 Q4 | 48.26 Thousand USD | -91.9% |
| 2024 Q3 | 595.89 Thousand USD | 187.36% |
| 2023 Q4 | 125.59 Thousand USD | -75.38% |
| 2023 Q3 | 510.1 Thousand USD | 128.46% |
| 2023 Q2 | 223.28 Thousand USD | 283.81% |
| 2023 Q1 | 58.17 Thousand USD | 4.89% |
| 2023 FY | 917.16 Thousand USD | 693.49% |
| 2022 Q2 | 4977.00 USD | 20.07% |
| 2022 FY | 115.58 Thousand USD | 818.95% |
| 2022 Q1 | 4145.00 USD | -21.42% |
| 2022 Q3 | 51 Thousand USD | 924.79% |
| 2022 Q4 | 55.46 Thousand USD | 8.74% |
| 2021 Q2 | 4790.00 USD | 138.78% |
| 2021 Q1 | 2006.00 USD | -35.04% |
| 2021 FY | 12.57 Thousand USD | 250.56% |
| 2021 Q3 | 507.00 USD | -89.42% |
| 2021 Q4 | 5275.00 USD | 940.43% |
| 2020 FY | 3588.00 USD | -95.4% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q2 | 7690.00 USD | 0.0% |
| 2020 Q3 | 500.00 USD | -93.5% |
| 2020 Q4 | 3088.00 USD | 517.6% |
| 2019 Q1 | - USD | 100.0% |
| 2019 Q4 | 77.93 Thousand USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | 77.93 Thousand USD | 5061.32% |
| 2018 FY | 1510.00 USD | -78.8% |
| 2018 Q4 | -2163.00 USD | -200.0% |
| 2018 Q3 | 2163.00 USD | 561.47% |
| 2018 Q1 | 1183.00 USD | 2528.89% |
| 2018 Q2 | 327.00 USD | -72.36% |
| 2017 FY | 7124.00 USD | -90.5% |
| 2017 Q1 | 2009.00 USD | 0.0% |
| 2017 Q4 | 45.00 USD | -97.92% |
| 2017 Q3 | 2163.00 USD | -25.59% |
| 2017 Q2 | 2907.00 USD | 44.7% |
| 2016 Q1 | 75 Thousand USD | 0.0% |
| 2016 FY | 75 Thousand USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | -100.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | 86.478% |
| Cerus Corporation | 156.36 Million USD | 99.38% |
| OrthoPediatrics Corp. | 148.73 Million USD | 99.349% |
| Talis Biomedical Corporation | 412 Thousand USD | -135.123% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 92.981% |
| Inogen, Inc. | 315.66 Million USD | 99.693% |
| Spectral AI, Inc. | 18.05 Million USD | 94.635% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 90.22% |
| CVRx, Inc. | 39.29 Million USD | 97.535% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -50.42% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.87% |
| Venus Concept Inc. | 76.35 Million USD | 98.731% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 91.967% |
| Bioventus Inc. | 512.34 Million USD | 99.811% |
| BrainsWay Ltd. | 31.78 Million USD | 96.952% |
| Envoy Medical, Inc. | 316 Thousand USD | -206.553% |
| electroCore, Inc. | 16.03 Million USD | 93.957% |
| IceCure Medical Ltd | 3.22 Million USD | 70.0% |
| Lucid Diagnostics Inc. | 2.42 Million USD | 60.103% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -165.4% |
| MaxCyte, Inc. | 41.28 Million USD | 97.654% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | 50.385% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -774.694% |
| PAVmed Inc | 2.45 Million USD | 60.493% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 95.698% |
| RxSight, Inc. | 89.07 Million USD | 98.913% |
| Sight Sciences, Inc. | 81.05 Million USD | 98.805% |
| SI-BONE, Inc. | 138.88 Million USD | 99.303% |
| TELA Bio, Inc. | 58.45 Million USD | 98.343% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 94.767% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 99.482% |
| LivaNova PLC | 1.15 Billion USD | 99.916% |
| 908 Devices Inc. | 50.22 Million USD | 98.071% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 99.799% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -1157.341% |
| NeuroPace, Inc. | 65.42 Million USD | 98.519% |
| LENSAR, Inc. | 42.16 Million USD | 97.703% |
| Apyx Medical Corporation | 52.34 Million USD | 98.15% |
| Cutera, Inc. | 212.36 Million USD | 99.544% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 97.096% |
| BioSig Technologies, Inc. | 18 Thousand USD | -5281.7% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 99.419% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 95.956% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.937% |
| Axonics, Inc. | 366.37 Million USD | 99.736% |
| Outset Medical, Inc. | 130.37 Million USD | 99.257% |
| IRIDEX Corporation | 51.86 Million USD | 98.132% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 99.289% |
| IRadimed Corporation | 65.56 Million USD | 98.522% |
| Tivic Health Systems, Inc. | 1.17 Million USD | 17.627% |
| INVO Bioscience, Inc. | 3.02 Million USD | 67.93% |
| Telesis Bio, Inc. | 27.5 Million USD | 96.479% |
| Viemed Healthcare, Inc. | 183 Million USD | 99.471% |
| Varex Imaging Corporation | 811 Million USD | 99.881% |
| Quipt Home Medical Corp. | 221.74 Million USD | 99.563% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 98.589% |
| Dynatronics Corporation | 32.53 Million USD | 97.022% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 88.837% |
| Semler Scientific, Inc. | 68.18 Million USD | 98.579% |
| InMode Ltd. | 492.04 Million USD | 99.803% |
| Bruker Corporation | 2.96 Billion USD | 99.967% |
| Cytosorbents Corporation | 36.34 Million USD | 97.335% |
| DexCom, Inc. | 3.62 Billion USD | 99.973% |
| Align Technology, Inc. | 3.86 Billion USD | 99.975% |
| Viveve Medical, Inc. | 6.42 Million USD | 84.925% |
| ZimVie Inc. | 457.43 Million USD | 99.788% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 99.498% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -774.694% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.87% |
| Profound Medical Corp. | 7.33 Million USD | 86.786% |
| Insulet Corporation | 1.69 Billion USD | 99.943% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 99.232% |
| iCAD, Inc. | 17.31 Million USD | 94.406% |
| Nuwellis, Inc. | 8.86 Million USD | 89.071% |
| Biotricity, Inc. | 12.06 Million USD | 91.97% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 99.803% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 84.388% |
| PAVmed Inc. | 2.45 Million USD | 60.493% |
| BIOLASE, Inc. | 49.16 Million USD | 98.03% |
| Beyond Air, Inc. | 1.15 Million USD | 16.419% |
| FONAR Corporation | 102.88 Million USD | 99.058% |
| AxoGen, Inc. | 159.01 Million USD | 99.391% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 99.647% |
| Inari Medical, Inc. | 493.63 Million USD | 99.804% |
| UFP Technologies, Inc. | 400.07 Million USD | 99.758% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -5108.097% |
| Tenon Medical, Inc. | 2.92 Million USD | 66.916% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 85.779% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.97% |
| Sintx Technologies, Inc. | 2.62 Million USD | 63.125% |
| NanoVibronix, Inc. | 2.28 Million USD | 57.569% |
| Quanterix Corporation | 122.36 Million USD | 99.208% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 96.031% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 99.517% |
| TransMedics Group, Inc. | 241.62 Million USD | 99.599% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 93.008% |
| NeuroMetrix, Inc. | 5.9 Million USD | 83.585% |
| Hyperfine, Inc. | 11.03 Million USD | 91.219% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 99.413% |
| Biomerica, Inc. | 5.41 Million USD | 82.111% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 98.084% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 99.453% |